Status:
ACTIVE_NOT_RECRUITING
Electroacupuncture for the Management of Symptom Clusters in Cancer Patients and Survivors
Lead Sponsor:
University of California, Irvine
Conditions:
Cancer
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
This is a sham-controlled, patient and assessor-blinded pilot trial to evaluate the feasibility of administering EA as an intervention for symptom clusters in cancer patients and survivors, and to eva...
Detailed Description
The purpose of this study is to investigate the efficacy, safety, and feasibility of offering electroacupuncture as an intervention to improve cancer-related symptoms (cognitive impairment, fatigue, p...
Eligibility Criteria
Inclusion
- Patients diagnosed with cancer that have received anti-cancer treatment
- 16 years of age or older
- Life expectancy ≥ 6 months
- Complaints of one or more of the following symptoms: memory impairment/attention deficit, fatigue, insomnia, depression, or anxiety over the past 7 days
Exclusion
- Presence of metastasis
- Severe needle phobia
- Severe psychiatric or medical disorders which would affect cognitive assessments
- Known bleeding disorder (e.g. hemophilia, Von Willebrand's disease, thrombocytopenia)
- Has pacemaker or other electronic metal implants
- Epilepsy
- Already receiving acupuncture therapy or received acupuncture treatment in the past 3 months.
- Breastfeeding, pregnant or are planning get pregnant during the study period
- Additional exclusion criteria for optional neuroimaging procedure:
- \- Has any contraindications to fMRI including metal fragments/implants in the body, sever claustrophobia, and non-removable metal orthodontic braces, metallic retainers and oral wires.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05283577
Start Date
April 15 2022
End Date
December 1 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCI Health Susan Samueli Integrative Health Institute
Irvine, California, United States, 92697